Mark Jalkut

582 total citations
9 papers, 316 citations indexed

About

Mark Jalkut is a scholar working on Pulmonary and Respiratory Medicine, Urology and Oncology. According to data from OpenAlex, Mark Jalkut has authored 9 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 2 papers in Urology and 2 papers in Oncology. Recurrent topics in Mark Jalkut's work include Prostate Cancer Treatment and Research (4 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Urinary Bladder and Prostate Research (2 papers). Mark Jalkut is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Urinary Bladder and Prostate Research (2 papers). Mark Jalkut collaborates with scholars based in United States, Canada and Netherlands. Mark Jalkut's co-authors include William J. Aronson, Frederick J. Dorey, Mark E. Sutter, Stephen J. Freedland, Steven E. Lerman, Robert E. Reiter, Bernard M. Churchill, Matthew E. Nielsen, C. Lance Cowey and Gayle Grigson and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Urology.

In The Last Decade

Mark Jalkut

9 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Jalkut United States 6 239 137 96 55 51 9 316
Yong-June Kim South Korea 12 262 1.1× 99 0.7× 52 0.5× 75 1.4× 58 1.1× 23 344
Viktor Eret Czechia 8 202 0.8× 166 1.2× 82 0.9× 26 0.5× 23 0.5× 65 289
Andrea Panunzio Italy 10 212 0.9× 67 0.5× 59 0.6× 31 0.6× 72 1.4× 80 346
Leonardo D. Borregales United States 14 390 1.6× 178 1.3× 68 0.7× 110 2.0× 34 0.7× 33 470
Norio Meguro Japan 10 251 1.1× 172 1.3× 60 0.6× 34 0.6× 20 0.4× 41 358
Fucai Tang China 11 205 0.9× 169 1.2× 96 1.0× 54 1.0× 21 0.4× 40 367
Jason W. Anast United States 9 306 1.3× 154 1.1× 62 0.6× 132 2.4× 46 0.9× 12 495
Tomáš Ürge Czechia 9 234 1.0× 174 1.3× 69 0.7× 21 0.4× 16 0.3× 53 287
François‐Xavier Nouhaud France 11 282 1.2× 81 0.6× 51 0.5× 36 0.7× 19 0.4× 36 362
Faruk Özcan Türkiye 11 133 0.6× 96 0.7× 27 0.3× 43 0.8× 41 0.8× 39 308

Countries citing papers authored by Mark Jalkut

Since Specialization
Citations

This map shows the geographic impact of Mark Jalkut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Jalkut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Jalkut more than expected).

Fields of papers citing papers by Mark Jalkut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Jalkut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Jalkut. The network helps show where Mark Jalkut may publish in the future.

Co-authorship network of co-authors of Mark Jalkut

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Jalkut. A scholar is included among the top collaborators of Mark Jalkut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Jalkut. Mark Jalkut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Tu, Le Mai, et al.. (2023). Management of female stress urinary incontinence with single‐incision mini‐sling (Altis®): 36 month multicenter outcomes. Neurourology and Urodynamics. 42(8). 1722–1732. 1 indexed citations
3.
Shore, Neal D., Elizabeth S. Cogan, Diana Iliev, et al.. (2022). Hereditary cancer risk assessment and genetic testing in the community urology practice setting. The Prostate. 82(7). 850–857. 2 indexed citations
4.
Neste, Leander Van, Kelvin A. Moses, Jonathan Silberstein, et al.. (2018). Evaluation of an Epigenetic Assay for Predicting Repeat Prostate Biopsy Outcome in African American Men. Urology. 128. 62–65. 26 indexed citations
5.
Neste, Leander Van, Mark Jalkut, Ronald Tutrone, et al.. (2017). PD07-04 CLINICAL PERFORMANCE OF AN EPIGENETIC ASSAY TO IDENTIFY OCCULT HIGH-GRADE PROSTATE CANCER IN AFRICAN AMERICAN MEN. The Journal of Urology. 197(4S). 2 indexed citations
6.
Cowey, C. Lance, Chirag Amin, Raj S. Pruthi, et al.. (2010). Neoadjuvant Clinical Trial With Sorafenib for Patients With Stage II or Higher Renal Cell Carcinoma. Journal of Clinical Oncology. 28(9). 1502–1507. 143 indexed citations
7.
Jalkut, Mark & Robert E. Reiter. (2002). Role of prostate stem cell antigen in prostate cancer research. Current Opinion in Urology. 12(5). 401–406. 23 indexed citations
8.
Jalkut, Mark, Steven E. Lerman, & Bernard M. Churchill. (2001). ENURESIS. Pediatric Clinics of North America. 48(6). 1461–1488. 36 indexed citations
9.
Freedland, Stephen J., Mark Jalkut, Frederick J. Dorey, Mark E. Sutter, & William J. Aronson. (2000). Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center. Urology. 56(1). 87–91. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026